Analyst Expectations For Amgen's Future
Analyst Expectations For Amgen's Future
分析師對安進未來的預期
An in-depth analysis of recent analyst actions unveils...Ratings for Amgen (NASDAQ:AMGN) were provided by 8 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
安進（納斯達克:AMGN）的分析師評級是在過去三個月內由8位分析師提供的，展示了看好和看淡觀點的混合。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了分析師們最近的評級，揭示了過去30天內情緒的變化並將其與前幾個月進行了比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $326.38, a high estimate of $381.00, and a low estimate of $215.00. Witnessing a positive shift, the current average has risen by 2.31% from the previous average price target of $319.00.
分析師對12個月價格目標的見解已經揭示，平均目標爲326.38美元，最高估值爲381.00美元，最低估值爲215.00美元。目前的平均目標價格比先前的319.00美元上漲了2.31％，呈現出積極的變化。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級：全面解析
An in-depth analysis of recent analyst actions unveils...
最新的分析師行動深...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。